Larry Mathis Financial Planning’s GSK GSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$325K Sell
6,742
-576
-8% -$29.4K 0.28% 72
2026
Q2
$384K Buy
+7,318
New +$387K 0.29% 84
2026
Q1
– Sell
-5,798
Closed -$284K – 164
2025
Q4
$284K Buy
+5,798
New +$270K 0.25% 114

Other funds holding GSK

Larry Mathis Financial Planning's GSK Position: Q3 2026 in Review

Larry Mathis Financial Planning reduced its GSK (GSK) stake by 7.9% in Q3 2026, selling an estimated $29.4K and leaving 6,742 shares worth $325K. The position accounts for 0.28% of the portfolio, ranked #72.

Larry Mathis Financial Planning first reported a position in GSK in Q4 2025 and has held it in 3 quarters since. The position peaked at $384K in Q2 2026. 993 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

  • Larry Mathis Financial Planning held 6,742 shares of GSK worth $325K as of Q3 2026.
  • Larry Mathis Financial Planning sold 576 GSK shares in Q3 2026, an estimated $29.4K.
  • GSK made up 0.28% of Larry Mathis Financial Planning's portfolio in Q3 2026, its #72 holding.
  • Larry Mathis Financial Planning first reported a position in GSK in Q4 2025 and has held it in 3 quarters since.
  • Larry Mathis Financial Planning's GSK position peaked at $384K in Q2 2026.
  • 993 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on Larry Mathis Financial Planning's 13F filing for Q3 2026, filed 26 Oct 2026.